Results 171 to 180 of about 1,442,598 (260)

Multiple Modes of Action of Anti-TNF-α Antibodies for Inflammatory Bowel Diseases Beyond TNF-α Neutralization. [PDF]

Antibodies (Basel)
Watanabe T, Kudo M.
europepmc   +1 more source

Guideline Concordance of ChatGPT‐Generated Responses on Antibiotic Prophylaxis in Endodontics

Journal of Dental Education, EarlyView.
ABSTRACT Antibiotic prophylaxis decision‐making in endodontics represents a core competency in dental education, requiring the integration of systemic risk assessment, guideline interpretation, and antimicrobial stewardship principles. Although artificial intelligence (AI) tools such as ChatGPT are increasingly accessed by students and clinicians for ...
Flavia Moura Medina Diniz, Pedro Rossato Lourenço, Antonio Miranda da Cruz‐Filho, Fabiane Carneiro Lopes‐Olhê, Jardel Francisco Mazzi‐Chaves, Laís Valencise Magri   +5 more
wiley   +1 more source

Evaluating the relationship between antidrug antibodies and efficacy and safety outcomes in patients with Fabry disease receiving enzyme replacement therapy: a systematic literature review. [PDF]

Orphanet J Rare Dis
Aguiar P, Bernat JA, Hughes D.
europepmc   +1 more source

Teorie e prassi nella formazione degli insegnanti: il Tirocinio del Corso di Laurea di Scienze della Formazione Primaria di Roma Tre. Una proposta comparativa

, 2023
Francesca Borruso, Amalia Lavinia Rizzo, Ada Manfreda, Borruso, Francesca, Rizzo, Amalia, Manfreda, Ada   +3 more
core   +1 more source

Low‐value glucose monitoring in noncritically ill hospitalized patients

Journal of Hospital Medicine, EarlyView.
Abstract Background Inpatient routine point‐of‐care glucose (POC‐G) monitoring is common given association of persistent hyperglycemia with increase in morbidity and mortality. However, some patients receive frequent fingerstick testing without needing insulin to reach glycemic targets.
Niloofar Latifi, Nestoras Mathioudakis, Mohammed S. Abusamaan, Megan M. Tschudy, Jianqiao Ma, Sarah Olson, Terra M. M. Jouaneh, Angie Yang, Daniel J. Brotman   +8 more
wiley   +1 more source

A Study of Clinico-Etiological Profiles and Outcomes of Pleural Effusion in a Tertiary Care Hospital. [PDF]

Cureus
Jakhalu K, Rakholia R, Chamoli P, Maroof M.   +3 more
europepmc   +1 more source

Inter‐Group Agreement in Chest Radiographic Quality Assessment: Comparing Final‐Year Students and Experienced Radiographers Across Three Quality Assessment Domains During the COVID‐19 Pandemic

Journal of Medical Radiation Sciences, EarlyView.
Final‐year radiography students and experienced radiographers assessed 70 chest radiographs using structured criteria for positioning, sharpness and anatomical visibility. The level of agreement was good to excellent across all three domains, with an overall ICC of 0.90.
Peter O'Reilly, Dania Abu Awwad, Ernest Ekpo, Warren Reed   +3 more
wiley   +1 more source

Peri‐implant disease pathogenesis animal models: Consensus report of Workgroup 1 of the IADR Implantology Research Group Best Evidence Consensus Symposium on Peri‐Implant Disease and Its Treatment

Journal of Periodontology, EarlyView.
Abstract Background The pathogenesis and etiology of peri‐implantitis demand a deeper understanding to lead to successful treatment modalities. Animal models of peri‐implantitis pathogenesis offer unique insights but their translational impact requires consideration of implant biomaterials science.
Georgios Kotsakis, Leonardo Mancini, Panos Afouxenides, Andrea Roccuzzo, IADR IRG Peri‐implantitis Best Evidence Consensus Working Group 1, Tara Aghaloo, Georgios Belibasakis, Nagihan Bostanci, Li Dehua, Nikolaos Donos, Alpdogan Kantarci, Alireza Moshaverinia, Flavia Pirih, Mia Rakic, Frank Schwarz, Sukirth Ganesan   +15 more
wiley   +1 more source

Detection of Anti-Infliximab and Anti-Adalimumab Antibodies Below Manufacture's Threshold in a TDM Cohort Using Signal-to-Noise Ratio. [PDF]

Basic Clin Pharmacol Toxicol
Pedersen L.
europepmc   +1 more source

Dual biologic therapy in inflammatory bowel disease, a retrospective cohort study of vedolizumab and anti‐tumor necrosis factor alpha therapy in children

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Despite advances in pediatric inflammatory bowel disease (PIBD) with biologics, remission rates remain at 47%–60% with loss‐of‐response rates at 60%–68%. Evidence for efficacy of dual biologic therapy (DBT) with anti‐tumor necrosis factor alpha therapy (anti‐TNF‐α)‐ vedolizumab (VDZ) for children refractory to anti‐TNF‐α therapy is ...
Jonathan E. M. O'Donnell, Carlie Bolles, Claire R. Reilly, Manal Morgan, Christopher Burgess, Fariha Balouch, Peter J. Lewindon   +6 more
wiley   +1 more source